Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly Declares Third-Quarter 2010 Dividend
Yahoo
Tuesday, June 22, 2010 - 8:54am
tags:
dividends, Eli Lilly
FDA: Pfizer will pull ineffective leukemia drug
Yahoo/AP
Tuesday, June 22, 2010 - 8:53am
tags:
FDA, Pfizer, leukemia, Mylotarg
Gaining the inside track on new biotech tax credit
Fierce Biotech
Tuesday, June 22, 2010 - 8:50am
tags:
biotech, tax credit
Bristol-Myers Dumps Exelixis Drug
Motley Fool
Monday, June 21, 2010 - 7:27pm
tags:
Bristol-Myers Squibb, Exelixis, cancer, partnerships
GSK, Merck tops at delivering meds to the poor
Fierce Pharma
Monday, June 21, 2010 - 12:12pm
tags:
GSK, Merck
Biosante Pharmaceuticals continues study of LibiGel drug for female sexual desire disorder
Yahoo/AP
Monday, June 21, 2010 - 12:09pm
tags:
BioSante, female sexual dysfunction, LibiGel
What Investors Think About Protalix BioTherapeutics
Motley Fool
Monday, June 21, 2010 - 12:08pm
tags:
investors, Protalix BioTherapeutics
Mead Johnson extends supply agreement with Martek
Yahoo/AP
Monday, June 21, 2010 - 12:07pm
tags:
infant formula, Mead Johnson, Martek
Good News for Immunomedics Pipeline
Yahoo/Zacks.com
Monday, June 21, 2010 - 12:05pm
tags:
Immunomedics, Human Genome Sciences, GSK, epratuzumab, UCB Pharmaceuticals, lupus
Court Allows New Trial in Hormone Therapy Case
NY Times, NY
Monday, June 21, 2010 - 12:04pm
tags:
HRT, Wyeth, Pfizer, breast cancer, Supreme Court
FDA grants approval for APP Pharmaceuticals drug
Yahoo/AP
Monday, June 21, 2010 - 10:31am
tags:
FDA, generics, APP, aztreonam, anti-infectives, Azactam, Bristol-Myers Squibb
Affymax Shares Fall on Hematide Drug’s Safety Concern
Bloomberg
Monday, June 21, 2010 - 10:27am
tags:
anemia, Affymax, Hematide
AstraZeneca's $103M Drug Pricing Settlement Is Merely Tip of the Over-Charging Iceberg
BNET Pharma
Monday, June 21, 2010 - 10:24am
tags:
AstraZeneca, settlements, drug pricing, Medicare fraud
Charles River Laboratories, WuXi PharmaTech: A Little Medicine for a Big Pharma Deal
Seeking Alpha
Monday, June 21, 2010 - 10:23am
tags:
Charles River Laboratories, WuXi PharmaTech, M&A
Do The Quants Have It In For Pfizer?
Forbes
Monday, June 21, 2010 - 9:43am
tags:
Pfizer, investors, quants
Boehringer Heart Drug Fails To Beat Aspirin
Pharmalot
Monday, June 21, 2010 - 9:41am
tags:
aspirin, Boehringer Ingelheim, Aggrenox, stroke
Myriad Pharmaceuticals: A Value Investor's Dream
Seeking Alpha
Monday, June 21, 2010 - 9:39am
tags:
Myriad
Valeant, Canada’s Biovail to Combine in Stock Deal
Bloomberg
Monday, June 21, 2010 - 9:34am
tags:
Valeant Pharmaceuticals, Canada, M&A, Biovail
The Market Is Wrong About Vanda
Seeking Alpha
Monday, June 21, 2010 - 9:24am
tags:
Vanda, Fanapt, schizophrenia
Exelixis regains rights to a cancer drug from BMY
Marketwatch
Monday, June 21, 2010 - 9:19am
tags:
Exelixis, Bristol-Myers Squibb, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.